Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ...
A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...
Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...
Here is a detailed profile on Google DeepMind CEO Demis Hassabis, including details on his achivements and personal life.
Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...
Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.
Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.
UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results